Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moses S Elisaf

Showing results (171-180 of 198) with videos related to

Pageof 20
Sort By:
International Urology and Nephrology|September 10, 2010
Abnormalities of serum potassium concentration in dialysis-associated hyperglycemia and their correction with insulin: review of published reportsAntonios H Tzamaloukas, Todd S Ing, Moses S Elisaf, et al.
European Journal of Pharmacology|October 13, 2007
Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemiaMichael S Kostapanos, Christos S Derdemezis, Theodosios D Filippatos, et al.
International Urology and Nephrology|September 21, 2010
Abnormalities of serum potassium concentration in dialysis-associated hyperglycemia and their correction with insulin: a unique clinical/physiologic exercise in internal potassium balanceAntonios H Tzamaloukas, Todd S Ing, Moses S Elisaf, et al.
American Heart Journal|October 2, 2004
Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemiaHaralampos J Milionis, Anna I Kakafika, Sofia G Tsouli, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|February 28, 2009
Dose-dependent effect of rosuvastatin treatment on HDL-subfraction phenotype in patients with primary hyperlipidemiaMichael S Kostapanos, Haralampos J Milionis, Theodosios D Filippatos, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|March 31, 2009
Galectin-2 (LGALS2) 3279C/T polymorphism may be independently associated with diastolic blood pressure in patients with rheumatoid arthritisVasileios F Panoulas, Karen M J Douglas, Jacqueline P Smith, et al.
Clinical Therapeutics|September 11, 2007
A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemiaMichael S Kostapanos, Haralampos J Milionis, Theodosios D Filippatos, et al.
Seminars in Dialysis|October 24, 2008
Pathophysiology and management of fluid and electrolyte disturbances in patients on chronic dialysis with severe hyperglycemiaAntonios H Tzamaloukas, Todd S Ing, Kostas C Siamopoulos, et al.
Lipids|June 21, 2011
Leptospirosis is associated with markedly increased triglycerides and small dense low-density lipoprotein and decreased high-density lipoproteinIrene F Gazi, Fotini A Apostolou, Evangelos N Liberopoulos, et al.
Journal of Diabetes and Its Complications|January 15, 2008
Body fluid abnormalities in severe hyperglycemia in patients on chronic dialysis: review of published reportsAntonios H Tzamaloukas, Todd S Ing, Kostas C Siamopoulos, et al.
Pageof 20

Showing results (171-180 of 198) with videos related to

Sort By:
Pageof 20
International Urology and Nephrology|September 10, 2010
Abnormalities of serum potassium concentration in dialysis-associated hyperglycemia and their correction with insulin: review of published reportsAntonios H Tzamaloukas, Todd S Ing, Moses S Elisaf, et al.
European Journal of Pharmacology|October 13, 2007
Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemiaMichael S Kostapanos, Christos S Derdemezis, Theodosios D Filippatos, et al.
International Urology and Nephrology|September 21, 2010
Abnormalities of serum potassium concentration in dialysis-associated hyperglycemia and their correction with insulin: a unique clinical/physiologic exercise in internal potassium balanceAntonios H Tzamaloukas, Todd S Ing, Moses S Elisaf, et al.
American Heart Journal|October 2, 2004
Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemiaHaralampos J Milionis, Anna I Kakafika, Sofia G Tsouli, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|February 28, 2009
Dose-dependent effect of rosuvastatin treatment on HDL-subfraction phenotype in patients with primary hyperlipidemiaMichael S Kostapanos, Haralampos J Milionis, Theodosios D Filippatos, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|March 31, 2009
Galectin-2 (LGALS2) 3279C/T polymorphism may be independently associated with diastolic blood pressure in patients with rheumatoid arthritisVasileios F Panoulas, Karen M J Douglas, Jacqueline P Smith, et al.
Clinical Therapeutics|September 11, 2007
A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemiaMichael S Kostapanos, Haralampos J Milionis, Theodosios D Filippatos, et al.
Seminars in Dialysis|October 24, 2008
Pathophysiology and management of fluid and electrolyte disturbances in patients on chronic dialysis with severe hyperglycemiaAntonios H Tzamaloukas, Todd S Ing, Kostas C Siamopoulos, et al.
Lipids|June 21, 2011
Leptospirosis is associated with markedly increased triglycerides and small dense low-density lipoprotein and decreased high-density lipoproteinIrene F Gazi, Fotini A Apostolou, Evangelos N Liberopoulos, et al.
Journal of Diabetes and Its Complications|January 15, 2008
Body fluid abnormalities in severe hyperglycemia in patients on chronic dialysis: review of published reportsAntonios H Tzamaloukas, Todd S Ing, Kostas C Siamopoulos, et al.
Pageof 20